205 related articles for article (PubMed ID: 30292135)
1. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
Yamayoshi S; Yasuhara A; Ito M; Uraki R; Kawaoka Y
J Clin Virol; 2018 Nov; 108():105-111. PubMed ID: 30292135
[TBL] [Abstract][Full Text] [Related]
2. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
3. Human Monoclonal Antibody Derived from Transchromosomic Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the Hemagglutinin Head Domain.
Gao R; Sreenivasan CC; Sheng Z; Hause BM; Zhou B; Wentworth DE; Clement T; Rausch D; Brunick C; Christopher-Hennings J; Wu H; Bausch CL; Sullivan EJ; Hoppe AD; Huber VC; Wang D; Li F
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847862
[TBL] [Abstract][Full Text] [Related]
4. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
[TBL] [Abstract][Full Text] [Related]
5. Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018.
Okuda M; Yamayoshi S; Uraki R; Ito M; Hamabata T; Kawaoka Y
Viruses; 2019 Apr; 11(4):. PubMed ID: 30987023
[TBL] [Abstract][Full Text] [Related]
6. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
Yamayoshi S; Ito M; Uraki R; Sasaki T; Ikuta K; Kawaoka Y
J Infect; 2018 Feb; 76(2):177-185. PubMed ID: 29248585
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
Tan GS; Lee PS; Hoffman RM; Mazel-Sanchez B; Krammer F; Leon PE; Ward AB; Wilson IA; Palese P
J Virol; 2014 Dec; 88(23):13580-92. PubMed ID: 25210195
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
[TBL] [Abstract][Full Text] [Related]
9. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin.
Schmeisser F; Friedman R; Besho J; Lugovtsev V; Soto J; Wang W; Weiss C; Williams O; Xie H; Ye Z; Weir JP
Influenza Other Respir Viruses; 2013 May; 7(3):480-90. PubMed ID: 23122228
[TBL] [Abstract][Full Text] [Related]
11. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus.
Ito M; Yamayoshi S; Murakami K; Saito K; Motojima A; Nakaishi K; Kawaoka Y
Viruses; 2019 Feb; 11(2):. PubMed ID: 30754701
[TBL] [Abstract][Full Text] [Related]
13. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
14. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
Shen W; Wang Q; Wang Z; Liu M; Du Y; Yuan L; Han L; Smietanka K; Chen H; Xu S; Zhu Q
J Virol; 2022 Sep; 96(18):e0123822. PubMed ID: 36037479
[TBL] [Abstract][Full Text] [Related]
15. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies.
Wyrzucki A; Bianchi M; Kohler I; Steck M; Hangartner L
J Virol; 2015 Mar; 89(6):3136-44. PubMed ID: 25552718
[TBL] [Abstract][Full Text] [Related]
16. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
17. A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.
Yamayoshi S; Uraki R; Ito M; Kiso M; Nakatsu S; Yasuhara A; Oishi K; Sasaki T; Ikuta K; Kawaoka Y
EBioMedicine; 2017 Mar; 17():182-191. PubMed ID: 28286060
[TBL] [Abstract][Full Text] [Related]
18. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
[TBL] [Abstract][Full Text] [Related]
19. Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
Chang P; Lukosaityte D; Sealy JE; Rijal P; Sadeyen JR; Bhat S; Crossley S; Daines R; Huang KA; Townsend AR; Iqbal M
J Virol; 2023 Jan; 97(1):e0143122. PubMed ID: 36541801
[TBL] [Abstract][Full Text] [Related]
20. Passive immunization with influenza haemagglutinin specific monoclonal antibodies.
Rudraraju R; Subbarao K
Hum Vaccin Immunother; 2018; 14(11):2728-2736. PubMed ID: 29985756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
